These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Drug therapy in liver diseases]. Zilly W Med Klin; 1979 Oct; 74(43):1575-80. PubMed ID: 44540 [No Abstract] [Full Text] [Related]
4. Drug kinetics and artificial kidneys. Gibson TB; Nelson HA Clin Pharmacokinet; 1977; 2(6):403-26. PubMed ID: 22417 [TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetic mechanisms of drug interactions. 3: Interaction mechanisms during distribution]. Box A; Heydel E; Fürtig W Pharmazie; 1984 Mar; 39(3):195-202. PubMed ID: 6728895 [No Abstract] [Full Text] [Related]
6. Current pharmacotherapy for the treatment of severe burns. Murphy KD; Lee JO; Herndon DN Expert Opin Pharmacother; 2003 Mar; 4(3):369-84. PubMed ID: 12614189 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic consequences of aging. Richey DP; Bender AD Annu Rev Pharmacol Toxicol; 1977; 17():49-65. PubMed ID: 326170 [No Abstract] [Full Text] [Related]
8. Neuromuscular blockers in patients with burns. Lancet; 1988 Oct; 2(8618):1003-4. PubMed ID: 2902437 [No Abstract] [Full Text] [Related]
10. Clinical pharmacokinetics in patients with burns. Jaehde U; Sörgel F Clin Pharmacokinet; 1995 Jul; 29(1):15-28. PubMed ID: 7586895 [TBL] [Abstract][Full Text] [Related]
11. Drug-protein interactions. Zia H Pahlavi Med J; 1978 Jul; 9(3):240-9. PubMed ID: 362352 [No Abstract] [Full Text] [Related]
12. Mechanisms of renal excretion of drugs (with special reference to drugs used by anaesthetists). Prescott LF Br J Anaesth; 1972 Mar; 44(3):246-51. PubMed ID: 4401573 [No Abstract] [Full Text] [Related]
13. Drug metabolism in patients with liver disease. Secor JW; Schenker S Adv Intern Med; 1987; 32():379-405. PubMed ID: 3548257 [No Abstract] [Full Text] [Related]
14. Interrelationship between renal haemodynamics, drug kinetics and drug action. Duchin KL; Schrier RW Clin Pharmacokinet; 1978; 3(1):58-71. PubMed ID: 346284 [No Abstract] [Full Text] [Related]
15. Resistance to competitive neuromuscular blocking agents in burn patients: a review. Owen RT Methods Find Exp Clin Pharmacol; 1985 Apr; 7(4):203-7. PubMed ID: 4021651 [TBL] [Abstract][Full Text] [Related]
16. Perioperative Pharmacologic Management of Patients with End Stage Renal Disease. Karambelkar A; Kasekar R; Palevsky PM Semin Dial; 2015; 28(4):392-6. PubMed ID: 25876523 [TBL] [Abstract][Full Text] [Related]
17. Influence of sex on drug kinetics in man. Giudicelli JF; Tillement JP Clin Pharmacokinet; 1977; 2(3):157-66. PubMed ID: 328204 [TBL] [Abstract][Full Text] [Related]
18. Perioperative anaphylaxis. Mertes PM; Tajima K; Regnier-Kimmoun MA; Lambert M; Iohom G; Guéant-Rodriguez RM; Malinovsky JM Med Clin North Am; 2010 Jul; 94(4):761-89, xi. PubMed ID: 20609862 [TBL] [Abstract][Full Text] [Related]
19. Drugs, receptors and serum protein binding. Kunin CM N Engl J Med; 1969 Nov; 281(21):1188-9. PubMed ID: 5347831 [No Abstract] [Full Text] [Related]
20. Clinical and professional reference guides. Critical values for therapeutic drug levels. Millar S MLO Med Lab Obs; 2001 Aug; 33(8 Suppl):15. PubMed ID: 11571829 [No Abstract] [Full Text] [Related] [Next] [New Search]